CC chemokine receptor 2 regulates leukocyte recruitment and IL-10 production during acute polymicrobial sepsis

被引:36
作者
Feterowski, C
Mack, M
Weighardt, H
Bartsch, B
Kaiser-Moore, S
Holzmann, B
机构
[1] Tech Univ Munich, Dept Surg, D-81675 Munich, Germany
[2] Univ Munich, Med Policlin, Munich, Germany
关键词
CCR2; MyD88; IL-10; polymicrobial sepsis;
D O I
10.1002/eji.200425294
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chemokine receptors are important for recruiting leukocytes to sites of infection and may contribute to immune cell activation. The present study investigated the role of the chemokine receptor CCR2 in polymicrobial septic peritonitis. The results showed that peritoneal production of the CCR2 ligands CCL2 and CCL12 in septic mice was largely independent of the common Toll-like receptor signaling adaptor MyD88. Antibody blockade of CCR2 reduced the recruitment of macrophages and neutrophils to the infected peritoneal cavities of both wild-type and MyD88-deficient mice, suggesting that CCR2 engagement contributes to the MyD88-independent cellular response against polymicrobial septic peritonitis. Notably, administration of blocking CCR2 antibodies markedly increased, local and systemic IL-10 levels in septic wild-type mice, whereas IL-10 was not detected in MyD88-deficient mice irrespective of whether CCR2 was blocked or not. Inhibition of CCR2 directly augmented Toll-like receptor-induced IL-10, but not TNF and IL-6, production of macrophages in vitro. Concomitant with enhanced IL-10 production, CCR2 blockade caused impaired bacterial clearance and aggravated kidney injury in wild-type, but not MyD88-null mice. These results indicate that CCR2 engagement modulates the innate immune response to polymicrobial septic peritonitis by both MyD88-dependent and -independent processes and suggest that a major function of CCR2 in sepsis is to attenuate IL-10 production and IL-10-mediated suppression of host defense.
引用
收藏
页码:3664 / 3673
页数:10
相关论文
共 57 条
[1]   Toll-like receptor signaling [J].
Akira, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (40) :38105-38108
[2]   MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR IS A POTENT HISTAMINE-RELEASING FACTOR FOR BASOPHILS [J].
ALAM, R ;
LETTBROWN, MA ;
FORSYTHE, PA ;
ANDERSONWALTERS, DJ ;
KENAMORE, C ;
KORMOS, C ;
GRANT, JA .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :723-728
[3]   The apoptotic signaling pathway activated by Toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Weiss, DS ;
Godowski, P ;
Zychlinsky, A .
EMBO JOURNAL, 2000, 19 (13) :3325-3336
[4]   INDUCTION OF NATURAL-KILLER-CELL MIGRATION BY MONOCYTE CHEMOTACTIC PROTEIN-1, PROTEIN-2 AND PROTEIN-3 [J].
ALLAVENA, P ;
BIANCHI, G ;
ZHOU, D ;
VANDAMME, J ;
JILEK, P ;
SOZZANI, S ;
MANTOVANI, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3233-3236
[5]   Endothelium-derived toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs [J].
Andonegui, G ;
Bonder, CS ;
Green, F ;
Mullaly, SC ;
Zbytnuik, L ;
Raharjo, E ;
Kubes, P .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (07) :1011-1020
[6]   Divergence of bacterial lipopolysaccharide pro-apoptotic signaling downstream of IRAK-1 [J].
Bannerman, DD ;
Tupper, JC ;
Erwert, RD ;
Winn, RK ;
Harlan, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :8048-8053
[7]   Toll-like receptors: how they work and what they do [J].
Beutler, B .
CURRENT OPINION IN HEMATOLOGY, 2002, 9 (01) :2-10
[8]   MONOCYTE CHEMOTACTIC PROTEIN-1 IS A POTENT ACTIVATOR OF HUMAN BASOPHILS [J].
BISCHOFF, SC ;
KRIEGER, M ;
BRUNNER, T ;
DAHINDEN, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (05) :1271-1275
[9]   Molecular cloning and functional expression of murine JE (Monocyte chemoattractant protein 1) and murine macrophage inflammatory protein la receptors - Evidence for two closely linked C-C chemokine receptors on chromosome 9 [J].
Boring, L ;
Gosling, J ;
Monteclaro, FS ;
Lusis, AJ ;
Tsou, CL ;
Charo, IF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7551-7558
[10]   Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice [J].
Boring, L ;
Gosling, J ;
Chensue, SW ;
Kunkel, SL ;
Farese, RV ;
Broxmeyer, HE ;
Charo, IF .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2552-2561